Hashimoto’s Thyroiditis: When Immune Defense Fails to Recover
Beyond autoimmunity: A bioenergetic perspective on environmental exposures, oxidative stress, immune regulation, and progressive thyroid failure
A newly published review in The Lancet Diabetes & Endocrinology, “Hashimoto’s thyroiditis: two decades on,” by Leonidas Duntas and Grigoris Effraimidis (2026), provides a timely synthesis of how our understanding of autoimmune thyroid disease has evolved.
The review brings together genetics, environmental exposures, immune dysregulation, oxidative stress, metabolic alterations, and progressive thyroid destruction. It also highlights important advances in diagnosis and treatment while acknowledging a major unresolved challenge: we still lack reliable ways to restore immune tolerance and prevent progressive thyroid failure.
The science is increasingly detailed. Yet an important question remains.
Why does an immune response that should protect us become persistent, progressively damaging the very organ it is responding to?
Our recently published perspective on bioenergetic impedance offers a potential governing framework connecting many of these mechanisms. Rather than viewing Hashimoto’s simply as an immune system attacking the thyroid, we propose examining how cumulative environmental exposures, metabolic constraints, compensatory responses, and insufficient recovery capacity might interact to sustain the disease.
This is not an established alternative explanation for Hashimoto’s. It is a systems-level hypothesis that builds upon the mechanisms described in the review and suggests new questions for investigation.
Hashimoto’s Begins Long Before Hypothyroidism
One of the review's most important contributions is its description of Hashimoto’s as a progressive disease involving declining thyroid reserve.
The authors outline four stages:
At risk: Genetic susceptibility exists, but thyroid function and immune tolerance are largely preserved.
Autoimmune activation: Thyroid antibodies appear, although thyroid hormone concentrations may remain normal.
Declining reserve: Progressive thyroid injury reduces functional capacity. TSH rises to compensate, while free T4 remains within the normal range.
Reserve exhaustion: Thyroid hormone production can no longer meet physiological requirements, producing overt hypothyroidism.
Importantly, not everyone with thyroid antibodies progresses to hypothyroidism. Some individuals remain functionally stable for years or decades, while others experience substantial deterioration.
This variation raises a fundamental question: What determines whether the thyroid successfully adapts, maintains compensation, or eventually loses its ability to recover?
The review identifies multiple contributors, including genetics, immune dysregulation, oxidative stress, and tissue remodelling. But these factors may also be understood as interacting processes in a progressive loss of physiological reserve.
Within our Respond–Adapt–Recover framework, overt hypothyroidism may represent the visible endpoint of a much longer process of cumulative stress, compensation, and incomplete recovery.
Environmental Exposures: More Than Disease Triggers
Hashimoto’s is often described as a genetically influenced autoimmune condition triggered by environmental factors.
The review discusses excess iodine, selenium deficiency, infections, medications, vitamin D status, psychological stress, and changes in the intestinal microbiome.
These influences are generally studied as individual risk factors.
However, throughout life, people rarely experience exposures one at a time.
They encounter mixtures of dietary chemicals, environmental pollutants, infections, medications, psychological stressors, nutritional imbalances, and metabolic demands.
This cumulative exposure environment—the exposome—could influence not only the likelihood of initiating an immune response but also the physiological resources available to contain and resolve it.
A biologically meaningful exposure does not necessarily need to cause overt poisoning or immediate tissue damage.
Repeated low-level exposures may influence antioxidant requirements, mitochondrial function, cellular repair, and immune regulation. Whether these changes become clinically important depends on exposure characteristics and individual susceptibility.
Our concept of Exposure-Related Malnutrition (ERM) proposes that nutrition should be evaluated not only through intake or circulating nutrient concentrations but also in relation to the cumulative resources required for adaptation, detoxification, repair, and recovery.
This distinction is particularly interesting in Hashimoto’s because the thyroid has unusually high oxidative demands.
The Thyroid Is an Oxidatively Demanding Organ
Thyroid hormone synthesis requires hydrogen peroxide (H₂O₂).
Thyroid peroxidase uses this oxidant to facilitate iodination of thyroglobulin and the production of thyroid hormones.
Under normal conditions, hydrogen peroxide production is tightly coordinated with antioxidant defence.
When oxidative generation exceeds protective and repair capacity, however, the same chemistry required for hormone synthesis can contribute to cellular injury.
The review highlights oxidative stress as an important mechanism in autoimmune thyroid disease, particularly when selenium-dependent antioxidant systems are inadequate.
Here, we propose an additional interpretation.
Persistent thyroid oxidative injury may continuously generate signals that prevent the immune response from fully resolving.
Damaged thyroid cells can release or expose endogenous danger-associated molecular patterns (DAMPs), while follicular disruption makes thyroid-specific autoantigens, including thyroglobulin (Tg) and thyroid peroxidase (TPO), available to the immune system.
DAMPs and autoantigens are not the same: DAMPs communicate cellular danger, whereas Tg and TPO are proteins that can become targets of autoreactive immunity.
Together, danger signalling and antigen presentation could reinforce inflammatory responses in individuals whose immune tolerance is already compromised.
This suggests a possible feedback loop:
Thyroid oxidative stress → cellular injury → danger signalling and autoantigen exposure → immune activation → additional thyroid injury.
The review provides evidence for oxidative injury, antigen presentation, inflammasome activation, and immune-mediated follicular destruction. Their integration into a self-sustaining DAMP-driven cycle remains a hypothesis requiring direct investigation.
But the question becomes important: is persistent autoimmune inflammation driven only by an overactive immune system, or partly by an organ that continues generating unresolved distress signals?
Selenium: A Connection Between Environmental Exposure and Thyroid Protection
The review discusses selenium deficiency as a potentially modifiable contributor to Hashimoto’s.
Selenium supports several important biological systems, including glutathione peroxidases, thioredoxin reductases, and iodothyronine deiodinases.
These systems contribute to antioxidant defence, cellular redox regulation, and thyroid hormone metabolism.
Interestingly, selenium biology also intersects with environmental toxicology.
Certain mercury compounds interact strongly with selenium-containing biological groups and can inhibit selenoenzymes such as thioredoxin reductase. Lead may interfere more indirectly with glutathione metabolism, antioxidant defences, and essential-element homeostasis.
This creates an intriguing possibility.
Functional selenium availability may depend not only on dietary selenium intake but also on environmental exposures and the demands placed upon selenium-dependent protective systems.
Such interactions might occur without classical symptoms of metal poisoning, although their clinical significance at low environmental exposure levels remains uncertain.
A normal circulating selenium concentration does not necessarily guarantee optimal activity of every selenium-dependent enzyme.
Equally, selenium supplementation does not automatically reverse metal-related effects, and excessive selenium intake can itself be harmful.
The broader point is that nutrient adequacy is dynamic.
A nutrient that is sufficient under one exposure and metabolic condition might become functionally constrained when physiological demands increase.
This is one reason we consider the relationship among environmental exposures, nutrient utilisation, redox balance, and physiological reserve central to personalised medicine.
Bioenergetic Impedance: When Cellular Demand Exceeds Effective Throughput
Our published bioenergetic impedance perspective describes a time-dependent constraint on energetic throughput and recovery relative to demand.
In simple terms, a cell or tissue may have energy-producing machinery but still struggle to deliver and coordinate the energy, substrates, redox balance, and repair processes required for its workload.
Under stress, biological systems adapt.
They may redirect substrates, change metabolic pathways, prioritise immediate survival functions, or recruit compensatory mechanisms.
These adaptations are often protective.
The problem arises when the underlying constraints remain unresolved.
Maintaining function becomes progressively more costly, recovery becomes slower, and previously adaptive responses may begin contributing to dysfunction.
This framework could help connect several observations discussed in the Hashimoto’s review.
Most importantly, it provides a possible explanation for why inflammatory activation can persist while immune counter-regulation becomes insufficient.
Why Inflammation Might Persist While Immune Regulation Weakens
One particularly interesting section of the review concerns the imbalance between inflammatory T-helper 17 (Th17) cells and regulatory T cells (Tregs).
Th17 cells are associated with pro-inflammatory signalling and rely substantially on glycolytic metabolic programmes.
Tregs, which help maintain immune tolerance and suppress inappropriate immune activation, depend importantly on mitochondrial oxidative metabolism for aspects of their stability and suppressive function.
These are not absolute distinctions: both cell populations use multiple metabolic pathways, and their requirements vary with activation and tissue conditions.
Nevertheless, the difference suggests a potentially important vulnerability.
When mitochondrial oxidative metabolism becomes constrained, cells may increase their reliance on glycolysis to compensate.
Such metabolic rerouting may help maintain certain inflammatory effector functions while potentially compromising aspects of counter-regulatory immunity that depend on intact mitochondrial and redox metabolism.
The result might be a metabolic asymmetry: the immune system retains sufficient capacity to sustain inflammation but struggles to complete the regulatory work necessary to resolve it.
This interpretation extends beyond the conventional description of excessive Th17 activity or insufficient Treg suppression.
It asks whether the imbalance might partly reflect underlying constraints on immune-cell metabolism and recovery.
The review also discusses abnormalities in regulatory B cells, which contribute to immune restraint through cytokines such as IL-10.
Thus, failure of regulation may involve several coordinated immune processes rather than a single cell population.
The proposed link between bioenergetic impedance and sustained immune dysregulation remains to be demonstrated in Hashimoto’s. But it offers a researchable explanation for why immune activation can become persistent even after the original triggering event has passed.
TSH Compensation: When Maintaining Function Becomes Increasingly Costly
Another important aspect of Hashimoto’s is the gradual rise in thyroid-stimulating hormone (TSH).
In conventional endocrine physiology, increasing TSH represents an adaptive response.
As thyroid hormone production begins to decline, the pituitary gland increases stimulation of the remaining thyroid tissue to maintain adequate circulating hormone concentrations.
This compensation can preserve thyroid function for years.
But compensation is not free.
TSH stimulates processes requiring substrates, protein synthesis, ion transport, redox regulation, and oxidative hormone biosynthesis.
What happens when the thyroid is already operating under bioenergetic and oxidative constraints?
We propose that increased TSH stimulation could, under certain conditions, raise the energetic workload of surviving thyroid follicular cells beyond their sustainable capacity.
This might create another feedback cycle:
Declining thyroid reserve → rising TSH → increased biosynthetic and oxidative workload → greater cellular stress → further reserve decline.
This does not mean TSH is inherently harmful. Its actions are normally adaptive, and TSH can also activate protective cellular pathways.
Rather, we suggest that the outcome of compensation depends on whether the tissue retains sufficient capacity to meet the additional workload and recover afterward.
This distinction is central to bioenergetic impedance.
A compensatory response can preserve function in the short term while potentially increasing the cost of maintaining that function when the underlying constraints remain unresolved.
It may also help explain why apparently normal thyroid hormone concentrations do not necessarily indicate that the thyroid is operating without substantial physiological strain.
From Compensation to Inflammatory Lock-In
The review describes progressive follicular injury, epitope spreading, persistent B-cell and T-cell activation, and eventual thyroid atrophy.
Our framework connects these findings through the dynamics of incomplete recovery.
A possible progression is:
Response: Environmental or tissue-specific challenges activate protective and inflammatory pathways.
Adaptation: Thyroid cells increase compensatory activity, immune cells undergo metabolic reprogramming, and inflammatory responses attempt to control the disturbance.
Increasing impedance: Persistent oxidative stress, resource competition, and metabolic constraints increase the cost of maintaining thyroid and immune functions.
Failed recovery: Danger signalling continues while counter-regulatory and reparative responses remain insufficient.
Lock-in: Repeated injury, immune-memory processes, epitope spreading, and structural tissue loss make it increasingly difficult to return to the original physiological state.
This may involve hysteresis: the biological system remains in an altered functional state even after the original initiating exposure has diminished or disappeared.
For example, an infection or oxidative insult might initiate immune activation, but the resulting tissue injury, altered metabolic organisation, and established autoimmune responses could help maintain inflammation long afterward.
Epigenetic remodelling may also contribute to the persistence of altered cellular programmes, although its causal role in this proposed sequence remains uncertain.
This is different from simply saying that inflammation becomes chronic.
It proposes that chronicity emerges when the processes sustaining the response outlast the system's capacity to restore its previous organisation.
In advanced disease, destruction of thyroid follicles creates an additional limitation: even successful control of autoimmunity might not restore tissue that has already been lost.
Why Some People Progress and Others Do Not
Perhaps the most important unanswered question is why Hashimoto’s follows such different trajectories.
Some individuals remain antibody-positive but euthyroid for decades.
Others gradually develop subclinical hypothyroidism.
Still others progress to substantial thyroid failure.
Genetics, antibody concentrations, and baseline TSH provide useful information, but they do not fully explain this heterogeneity.
Our framework proposes that the trajectory may also depend on interacting physiological capacities:
The burden and persistence of environmental exposures and local thyroid injury.
The availability and functionality of protective resources, including selenium-dependent redox systems.
The ability of thyroid cells to maintain energetic throughput under increasing TSH stimulation.
The metabolic flexibility and suppressive competence of regulatory immune populations.
The efficiency of damage clearance, tissue repair, and restoration of immune tolerance.
These factors might help determine whether repeated challenges produce successful recovery, compensated chronic inflammation, or progressive structural deterioration.
An important implication is that measuring the immune response alone may be insufficient.
We may also need to understand the capacity to resolve that response.
What This Means for Treatment
The review appropriately emphasises that levothyroxine remains the established treatment for overt hypothyroidism.
Replacing deficient thyroid hormone is essential when thyroid production becomes inadequate.
However, hormone replacement does not necessarily reverse the underlying autoimmune process or regenerate destroyed thyroid tissue.
Likewise, although selenium supplementation can reduce thyroid antibody concentrations in some studies, clinical benefits and prevention of disease progression have not been consistently demonstrated.
The bioenergetic perspective does not replace conventional treatment or justify unproven detoxification or immune-modulating interventions.
Instead, it suggests additional questions for future personalised care and research.
Could evaluating environmental exposure, redox function, metabolic reserve, and immune recovery help identify individuals at greater risk of progression?
Could interventions addressing demonstrated nutritional deficiencies, excessive exposures, or reversible metabolic constraints improve the conditions necessary for immune resolution?
And, most importantly, could these approaches be tested early enough to preserve thyroid reserve before irreversible destruction occurs?
Answering these questions requires properly designed longitudinal and interventional studies, not simply observing correlations between biomarkers and autoantibody concentrations.
Beyond Hashimoto’s: A Broader Principle of Chronic Disease
Hashimoto’s is particularly interesting because its progression can be followed through measurable stages.
We can observe thyroid antibodies, compensatory TSH elevation, changes in thyroid hormone production, ultrasonographic abnormalities, and eventual loss of function.
These provide an opportunity to investigate how environmental stress, immune regulation, metabolic compensation, and tissue reserve interact over time.
But the governing principle may extend beyond the thyroid.
Similar patterns of persistent inflammation, compensatory metabolic changes, incomplete recovery, and progressive reserve loss are being investigated across chronic inflammatory, metabolic, and age-related diseases.
In each case, a central question may be whether the body is still responding adaptively—or whether the cost of maintaining that adaptation has begun to exceed its capacity for recovery.
Our bioenergetic impedance perspective proposes that disease progression may sometimes be better understood not only by identifying what has become activated or damaged, but also by examining what prevents the system from resolving the disturbance and restoring function.
The Missing Question: What Prevents Recovery?
Duntas and Effraimidis provide an important and timely synthesis of Hashimoto’s thyroiditis.
Their review shows how far research has progressed in identifying genetic susceptibility, environmental triggers, immune mechanisms, oxidative stress, and the gradual loss of thyroid reserve.
Our proposed contribution is to connect these components through a broader governing framework.
Environmental exposures may increase metabolic and redox demands. Bioenergetic impedance may constrain the immune system's ability to sustain counter-regulatory responses. Persistent thyroid oxidative injury may continue generating danger signals and exposing autoantigens. Meanwhile, compensatory TSH stimulation may increase the workload of surviving thyroid tissue.
Together, these processes could reinforce one another, transforming initially protective responses into persistent inflammation, costly compensation, and eventual tissue-level lock-in.
The fundamental problem may not be simply that the immune system attacks the thyroid. It may be that the thyroid and immune system become trapped in an energetically costly response that neither can fully resolve.
This remains a hypothesis rather than an established explanation of Hashimoto’s thyroiditis. Its value lies in generating measurable predictions and identifying potentially reversible constraints before organ failure becomes irreversible.
The future of autoimmune thyroid research may therefore depend not only on understanding how immunity is activated, but also on understanding what it takes—energetically, metabolically, and physiologically—for immunity to recover.
References
Duntas, L. H., & Effraimidis, G. (2026). Hashimoto’s thyroiditis: Two decades on. The Lancet Diabetes & Endocrinology. Advance online publication. https://doi.org/10.1016/S2213-8587(26)00189-0
Tippairote, T. (2026). Bioenergetic impedance perspective. Frontiers in Network Physiology. https://doi.org/10.3389/fnetp.2026.1967461
Note: The bioenergetic interpretation presented here is a conceptual extension of established thyroid immunopathology. It is intended to stimulate research and does not constitute a validated diagnostic framework or treatment recommendation.
Comments